Abstract
Many unexpected problems have resulted from the unprecedented coronavirus disease 2019 (COVID-19) pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been a challenge. Therefore, the Korean Association for the Study of Intestinal Diseases (KASID) developed a consensus statement of experts regarding the management of IBD during the COVID-19 pandemic. This consensus statement made recommendations regarding the risk and treatment of COVID-19 in IBD patients.
Original language | English |
---|---|
Pages (from-to) | 431-444 |
Number of pages | 14 |
Journal | Intestinal Research |
Volume | 20 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2022 |
Bibliographical note
Publisher Copyright:© Copyright 2022. Korean Association for the Study of Intestinal Diseases. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords
- Covid-19
- Inflammatory bowel disease
- Management
- Sars-cov-2